In addition to hematopoietic stem cells, cord blood (CB) also contains different nonhematopoietic CD45−, CD34− adherent cell populations: cord blood mesenchymal stromal cells (CB MSC) that behave almost like MSC from bone marrow (BM MSC) and unrestricted somatic stem cells (USSC) that differentiate into cells of all 3 germ layers. Distinguishing between these populations is difficult due to overlapping features such as the immunophenotype or the osteogenic and chondrogenic differentiation pathway. Functional differences in the differentiation potential suggest different developmental stages or different cell populations. Here we demonstrate that the expression of genes and the differentiation toward the adipogenic lineage can discriminate between these 2 populations. USSC, including clonal-derived cells lacking adipogenic differentiation, strongly expressed δ-like 1/preadipocyte factor 1 (DLK-1/PREF1) correlating with high proliferative potential, while CB MSC were characterized by a strong differentiation toward adipocytes correlating with a weak or negative DLK-1/PREF1 expression. Constitutive overexpression of DLK-1/PREF1 in CB MSC resulted in a reduced adipogenic differentiation, whereas silencing of DLK-1 in USSC resulted in adipogenic differentiation.
Get full access to this article
View all access options for this article.
References
1.
EapenM, RubinsteinP, ZhangMJ, StevensC, KurtzbergJ, ScaradavouA, LoberizaFR, ChamplinRE, KleinJP, HorowitzMM, WagnerJE. 2007. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet, 369:1947–1954.
2.
GluckmanE, RochaV. EBMT Paediatric, Acute Leukemia Working Parties; Eurocord. 2008. Indications and results of cord blood transplant in children with leukemia. Bone Marrow Transplant, 41,Suppl. 2:S80–S82.
3.
RochaV, GluckmanE. 2007. Outcomes of transplantation in children with acute leukaemia. Lancet, 369:1906–1908.
4.
KöglerG, SenskenS, AireyJA, TrappT, MüschenM, FeldhahnN, LiedtkeS, SorgRV, FischerJ, RosenbaumC, GreschatS, KnipperA, BenderJ, DegistiriciO, GaoJ, CaplanAI, CollettiEJ, Almeida-PoradaG, MüllerHW, ZanjaniE, WernetP. 2004. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med, 200:123–135.
5.
ChanSL, ChoiM, WnendtS, KrausM, TengE, LeongHF, MerchavS. 2007. Enhanced in vivo homing of uncultured and selectively amplified cord blood CD34+ cells by cotransplantation with cord blood-derived unrestricted somatic stem cells. Stem Cells, 25:529–536.
6.
ChangYJ, ShihDT, TsengCP, HsiehTB, LeeDC, HwangSM. 2006. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells, 24:679–685.
7.
KernS, EichlerH, StoeveJ, KliiterH, BiebackK. 2006. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells, 24:1294–1301.
8.
KimBO, TianH, PrasongsukarnK, WuJ, AngoulvantD, WnendtS, MuhsA, SpitkovskyD, LiRK. 2005. Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation, 112:I96–104.
9.
KöglerG, CritserP, TrappT, YoderM. 2009. Future of cord blood for non-oncology uses. Bone Marrow Transplant, 44:683–697.
10.
van den BerkLC, JansenBJ, Siebers-VermeulenKG, NeteaMG, LatuhihinT, BergevoetS, RaymakersRA, KoglerG, FigdorCC, AdemaGJ, TorensmaR. 2009. Toll-like receptor triggering in cord blood mesenchymal stem cells. J Cell Mol Med, 13:3415–3426.
11.
WinterM, WangXN, DaubenerW, EykingA, RaeM, DickinsonAM, WernetP, KoglerG, SorgRV. 2008. Suppression of cellular immunity by cord blood-derived unrestricted somatic stem cells is cytokine dependent. J Cell Mol Med, 13:2465–2475.
12.
JansenBJ, GilissenC, RoelofsH, Schaap-OziemlakA, VeltmanJ, RaymakersRA, JansenJ, KoglerG, FigdorCG, TorensmaR, AdemaGJ. 2009. Functional differences between mesenchymal stem cell populations are reflected by their transcriptome. Stem Cells Dev, 19:481–490.
13.
GreschatS, SchiraJ, KüryP, RosenbaumC, de Souza SilvaMA, KöglerG, WernetP, MüllerHW. 2008. Unrestricted somatic stem cells from human umbilical cord blood can be differentiated into neurons with a dopaminergic phenotype. Stem Cells Dev, 17:221–232.
14.
KoglerG, SenskenS, WernetP. 2006. Comparative generation and characterization of pluripotent unrestricted somatic stem cells with mesenchymal stem cells from human cord blood. Exp Hematol, 34:1589–1595.
15.
SenskenS, WaclawczykS, KnauppAS, TrappT, EnczmannJ, WernetP, KoglerG. 2007. In vitro differentiation of human cord blood-derived unrestricted somatic stem cells towards an endodermal pathway. Cytotherapy, 9:362–378.
KöglerG, RadkeTF, LefortA, SenskenS, FischerJ, SorgRV, WernetP. 2005. Cytokine production and hematopoiesis supporting activity of cord blood-derived unrestricted somatic stem cells. Exp H ematol, 33:573–583.
18.
HillAJ, ZwartI, TarnHH, ChanJ, NavarreteC, JenLS, NavarreteR. 2009. Human umbilical cord blood-derived mesenchymal stem cells do not differentiate into neural cell types or integrate into the retina after intravitreal grafting in neonatal rats. Stem Cells Dev, 18:399–409.
19.
LabordaJ, SausvilleEA, HoffmanT, otarioV. 1993. dlk, a putative mammalian homeotic gene differentially expressed in small cell lung carcinoma and neuroendocrine tumor cell line. J Biol Chem, 268:3817–3820.
20.
SmasCM, SulHS. 1993. Pref-1, a protein containing EGF-like repeats, inhibits adipocyte differentiation. Cell, 73:725–734.
21.
SmasCM, ChenL, SulHS. 1997. Cleavage of membrane-associated pref-1 generates a soluble inhibitor of adipocyte differentiation. Mol Cell Biol, 17:977–988.
22.
FloridonC, JensenCH, ThorsenP, NielsenO, SundeL, WestergaardJG, ThomsenSG, TeisnerB. 2000. Does fetal antigen 1 (FA1) identify cells with regenerative, endocrine and neuroendocrine potentials? A study of FA1 in embryonic, fetal, and placental tissue and in maternal circulation. Differentiation, 66:49–59.
TanimizuN, NishikawaM, SaitoH, TsujimuraT, MiyajimaA. 2003. Isolation of hepatoblasts based on the expression of Dlk/Pref-1. J Cell Sci, 116,Pt 9:1775–1786.
27.
AnisimovSV, TarasovKV, TweedieD, SternMD, WobusAM, BohelerKR. 2002. SAGE identification of gene transcripts with profiles unique to pluripotent mouse R1 embryonic stem cells. Genomics, 79:169–176.
28.
MooreKA, PytowskiB, WitteL, HicklinD, LemischkaIR. 1997. Hematopoietic activity of a stromal cell transmembrane protein containing epidermal growth factor-like repeat motifs. Proc Natl Acad Sci USA, 94:4011–4016.
29.
RadkeTF, BuchheiserA, LefortA, MalekiM, WernetP, KoglerG. 2007. GMP-conform generation and cultivation of unrestricted somatic stem cells (USSC) from cord blood using the SEPAX-separation method and a closed culture system applying cell stacks. Blood, 110:367.
30.
LiedtkeS, EnczmannJ, WaclawczykS, WernetP, KoglerG. 2007. Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell, 1:364–366.
31.
LiedtkeS, StephanM, KöglerG. 2008. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol Chem, 389:845–850.
32.
TakahashiK, TanabeK, OhnukiM, NaritaM, IchisakaT, TomodaK, YamanakaS. 2007. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131:861–872.
33.
GreenbergAS, EganJJ, WekSA, GartyNB, Blanchette-MackieEJ, LondosC. 1991. Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. J Biol Chem, 266:11341–11346.
34.
BiancoP, RobeyPG. 2001. Stem cells in tissue engineering. Nature, 414:118–121.
35.
CaplanAI. 2009. Why are MSCs therapeutic? New data: new insight. J Pathol, 217:318–324.
LeeK, VillenaJA, MoonYS, KimKH, LeeS, KangC, SulHS. 2003. Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1)J Clin Invest, 111:453–461.
46.
SamulewiczSJ, SeitzA, ClarkL, Heber-KatzE. 2002. Expression of preadipocyte factor-1(Pref-1), a delta-like protein, in healing mouse ears. Wound Repair Regen, 10:215–221.
47.
YevtodiyenkoA, SchmidtJV. 2006. Dlkl expression marks developing endothelium and sites of branching morphogenesis in the mouse embryo and placenta. Dev Dyn, 235:1115–1123.
48.
LiL, FormanSJ, BhatiaR. 2005. Expression of DLK1 in hematopoietic cells results in inhibition of differentiation and proliferation. Oncogene, 24:4472–4476.
49.
JensenCH, TeisnerB, HøjrupP, RasmussenHB, MadsenOD, NielsenB, SkjødtK. 1993. Studies on the isolation, structural analysis and tissue localization of fetal antigen 1 and its relation to a human adrenal-specific cDNA, pG2. Hum Reprod, 8:635–641.
50.
LarsenJB, JensenCH, SchroderHD, TeisnerB, BjerreP, HagenC. 1996. Fetal antigen 1 and growth hormone in pituitary somatotroph cells. Lancet, 347:191.
51.
WhiteJD, VuocoloT, McDonaghM, GroundsMD, HarperGS, CockettNE, TellamR. 2008. Analysis of the callipyge phenotype through skeletal muscle development; association of Dlkl with muscle precursor cells. Differentiation, 76:283–298.
LiedtkeS, BuchheiserA, BoschJ, BosseF, KruseF, ZhaoX, SantourlidisS, KöglerG. 2010. The HOX code as a “biological fingerprint” to distinguish functionally distinct stem cell populations derived from cord blood. Stem Cell Res, 5:40–50.
54.
CharbordP, TavianM, HumeauL, PéaultB. 1996. Early ontogeny of the human marrow from long bones: an immunohistochemical study of hematopoiesis and its microenvironment. Blood, 87:4109–4119.
55.
WangY, SulHS. 2009. Pref-1 regulates mesenchymal cell commitment and differentiation through Sox9. Cell Metab, 9:287–302.
56.
GimbleJM, RobinsonCE, WuX, KellyKA. 1996. The function of adipocytes in the bone marrow stroma: an update. Bone, 19:421–428.
57.
BaladronV, Ruiz-HidalgoMJ, NuedaML, Díaz-GuerraMJ, García-RamírezJJ, BonviniE, GubinaE, LabordaJ. 2005. dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats. Exp Cell Res, 303:343–359.
58.
GarcésC, Ruiz-HidalgoMJ, Font de MoraJ, ParkC, MieleL, GoldsteinJ, BonviniE, PorrásA, LabordaJ. 1997. Notch-1 controls the expression of fatty acid-activated transcription factors and is required for adipogenesis. J Biol Chem, 272:29729–29734.
59.
MicchelliCA, RulifsonEJ, BlairSS. 1997. The function and regulation of cut expression on the wing margin of Drosophila Notch, Wingless and a dominant negative role for Delta and Serrate. Development, 124:1485–1495.
60.
de CelisJF, BraySJ. 2000. The Abruptex domain of Notch regulates negative interactions between Notch, its ligands and Fringe. Development, 127:1291–1302.
61.
BraySJ, TakadaS, HarrisonE, ShenSC, Ferguson-SmithAC. 2008. The atypical mammalian ligand Delta-like homologue 1 (Dlk1) can regulate Notch signalling in Drosophila. BMC Dev Biol, 8:11.
62.
TanimizuN, MiyajimaA. 2004. Notch signaling controls hepatoblast differentiation by altering the expression of liver-enriched transcription factors. J Cell Sci, 117,Pt15:3165–3174.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
